SCHEMBL24596160

SCHEMBL24596160

CC1=C(C)OCCC(=O)N1

nearest known ligand 0.38

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 3/20 0.38
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12641090 0.76
SCHEMBL7220065 0.70
SCHEMBL17948964 0.65
SCHEMBL4744971 0.64
SCHEMBL14075355 0.62 CRBN (0.54) CRBN
SCHEMBL14075351 0.62 CRBN (0.48) CRBN
Succinimide SCHEMBL27636426 0.61
SCHEMBL3813709 0.60
Succinimide SCHEMBL938031 0.60 CRBN (0.61) CRBNALDH1A1LMNATP53TSHR
SCHEMBL24596145 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4273146-A1 TRICYCLIC COMPOUND AND USE THEREOF Nanjing Zaiming Pharmaceutical Co., Ltd. (CN) 2023-11-08 EP disclosed
WO-2022143864-A1 TRICYCLIC COMPOUND AND USE THEREOF 江苏先声药业有限公司 2022-07-07 WO disclosed